Skip to main content
logo
Satellos Bioscience Inc. (TSX:MSCL)
Canada flag Canada · Delayed Price · Currency is CAD
9.50
-0.40 (-4.04%)
Oct 14, 2026, 3:56 PM EST

Satellos Bioscience Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
-9.48-1.51-0.6-6.68-2.76-1.6
Operating Income
-35.82-26.46-20.4-11.71-6.23-3.77
Net Income
-34.61-24.87-20.63-12.03-8.37-12.25
Earnings Per Share
-1.99-1.70-2.16-1.67-2.81-6.11
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
61.8427.7148.5529.981.423.85
Total Debt
------
Net Cash (Debt)
61.8427.7148.5529.981.423.85
Net Cash Growth
61.81%-42.92%61.96%2008.62%-63.07%-
Net Cash Per Share
3.561.905.084.160.481.92

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-29-23.6-18.25-8.77-4.17-3.98
Capital Expenditures
-0.01-0.01-0-0.01-0-0.01
Free Cash Flow
-29.01-23.6-18.26-8.79-4.17-3.98
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Selected indicators aren't available for this stock.